Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

IGC IGC Pharma, Inc.
$0.29 -1.17% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy IGC stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 26.6M
Enterprise value 25.3M
Trailing PE -3.107777900166
Forward PE -3.1444442
PEG Ratio -3.1444442
Enterprise to EBITDA -3.362
Enterprise to revenue 22.873
Price to book MRQ 3.215909
Price to sales TTM 24.318047

Financials

Fiscal Year Ends 2025-03-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 1.1M
EBITDA -7524000
Diluted EPS TTM -0.07
Total Cash (MRQ) 1.1M
Current ratio (MRQ) 1.324
Operating Cash Flow (TTM) -5544000

IGC trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent IGC News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.